News
Watch
Journals
Conferences
Events
Resources
CE
About AJMC
Subscribe

Spotlight -

Free In-Person Regional Events Focused on Oncology and Population Health

Opinion|Videos|October 25, 2024

Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis

Author(s)Ryan Haumschild, PharmD, MS, MBA, Jorge Larranaga, MD, Jeremy Wigginton, MD

Panelists discuss how health care providers and payers can collaborate more effectively to optimize lupus nephritis care.

Episodes in this series

EP. 1 Understanding the Clinical Burden and Prevalence of Lupus Nephritis

EP. 1 Understanding the Clinical Burden and Prevalence of Lupus Nephritis

EP. 2 Cost Drivers in Lupus Nephritis

EP. 2 Cost Drivers in Lupus Nephritis

EP. 3 Urgency to Treat in Lupus Nephritis: Goals of Therapy and Early Diagnosis Strategies

EP. 3 Urgency to Treat in Lupus Nephritis: Goals of Therapy and Early Diagnosis Strategies

EP. 4 Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making

EP. 4 Guideline Updates in Lupus Nephritis: Impacts on Clinical Decision-Making

EP. 5 Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches

EP. 5 Tailoring Lupus Nephritis Treatment: Key Considerations and Specialist Approaches

EP. 6 Belimumab and Voclosporin: Clinical Insights and Payer Evaluations in Lupus Nephritis

EP. 6 Belimumab and Voclosporin: Clinical Insights and Payer Evaluations in Lupus Nephritis

EP. 7 Improving Access to Lupus Nephritis Treatment: Strategies and Resources

EP. 7 Improving Access to Lupus Nephritis Treatment: Strategies and Resources

EP. 8 Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results

EP. 8 Lupus Nephritis Management: Monitoring Strategies and Long-Term Study Results

EP. 9 Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis

EP. 9 Collaborating for Better Care: Healthcare Providers and Payers in Lupus Nephritis

1 KOL is featured in this series.

EP. 10 From Guidelines to Practice: Advancing Lupus Nephritis Treatment

1 KOL is featured in this series.

EP. 11 Looking Ahead: Anticipating Changes in Lupus Guidelines and Clinical Practice

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Inside the Pivotal Trials Shaping Vitiligo Treatment Choices

ByRyan Haumschild, PharmD, MBA,David Rosmarin, MD,Seemal R. Desai, MD, FAAD,Jason Fehr, MA,Karan Lal, DO, MS, FAAD

August 26th 2026

Payer Perspectives on Topical Versus Oral JAK Selectivity

ByRyan Haumschild, PharmD, MBA,David Rosmarin, MD,Seemal R. Desai, MD, FAAD,Jason Fehr, MA,Karan Lal, DO, MS, FAAD

August 26th 2026

5 experts are featured in this series

Catching Alzheimer's Disease Early: Assessing Mild Cognitive Impairment in Primary Care

ByKavita Nair, PhD,Joshua Oaks, MD,Scott Joy, MD, MBA, FACP,Jennifer Woodward, MD, MPH,Dylan Gallacher, PA

August 25th 2026

5 experts are featured in this series

Alzheimer's Disease Prevalence and Prevention: Building the Case for Early Diagnosis

ByKavita Nair, PhD,Joshua Oaks, MD,Scott Joy, MD, MBA, FACP,Jennifer Woodward, MD, MPH,Dylan Gallacher, PA

August 25th 2026

Complementary, Not Competing: How an Endocrinologist Compares Dual Incretin Approaches for Obesity and MASH

ByJaime Almandoz, MD, MBA

August 21st 2026

Trending on AJMC

Daraxonrasib Clears FDA as First RAS-Targeted Pancreatic Cancer Drug

As GLP-1 Costs Climb, Medicare Part D Plans Face a Reckoning

New York Experts Push for Coordinated Obesity Care Teams

Grocery Assistance Benefit Linked to Fewer Diabetes Complications

Early Secukinumab Sustains Psoriasis Clearance a Year After Stopping